<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7278987\results\search\disease\results.xml">
  <result pre="BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Following the outbreak of novel severe" exact="acute" post="respiratory syndrome (SARS)-coronavirus (CoV)2, the majority of nations are"/>
  <result pre="license (http://creativecommons.org/licenses/by/4.0/). Abstract Following the outbreak of novel severe acute" exact="respiratory" post="syndrome (SARS)-coronavirus (CoV)2, the majority of nations are struggling"/>
  <result pre="(http://creativecommons.org/licenses/by/4.0/). Abstract Following the outbreak of novel severe acute respiratory" exact="syndrome" post="(SARS)-coronavirus (CoV)2, the majority of nations are struggling with"/>
  <result pre="is no strong consensus on how to treat the coronavirus" exact="disease" post="2019 (COVID-19) associated viral pneumonia. Coronaviruses code for an"/>
  <result pre="on how to treat the coronavirus disease 2019 (COVID-19) associated" exact="viral pneumonia." post="Coronaviruses code for an important multifunctional enzyme named papain-like"/>
  <result pre="roles in pathogenesis. First, PLP is one of the two" exact="viral" post="cysteine proteases, along with 3-chymotripsin-like protease, that is responsible"/>
  <result pre="responsible for the production of the replicase proteins required for" exact="viral" post="replication. Second, its intrinsic deubiquitinating and deISGylating activities serve"/>
  <result pre="papain-like protease PLP inhibitors COVID-19 COVID-19 therapy 1. Introduction A" exact="pneumonia" post="of unknown cause was detected in Wuhan, Peopleâ€™s Republic"/>
  <result pre="discovered to be a novel coronavirus (CoV) and named severe" exact="acute" post="respiratory syndrome (SARS)-CoV2, based on sequence similarity with members"/>
  <result pre="to be a novel coronavirus (CoV) and named severe acute" exact="respiratory" post="syndrome (SARS)-CoV2, based on sequence similarity with members of"/>
  <result pre="be a novel coronavirus (CoV) and named severe acute respiratory" exact="syndrome" post="(SARS)-CoV2, based on sequence similarity with members of the"/>
  <result pre="MERS-CoV, two highly pathogenic coronaviruses responsible for previous epidemics of" exact="Severe" post="Acute Respiratory Syndrome and Middle-East Respiratory Syndrome, respectively [1,2,3,4]."/>
  <result pre="two highly pathogenic coronaviruses responsible for previous epidemics of Severe" exact="Acute" post="Respiratory Syndrome and Middle-East Respiratory Syndrome, respectively [1,2,3,4]. Genomes"/>
  <result pre="highly pathogenic coronaviruses responsible for previous epidemics of Severe Acute" exact="Respiratory" post="Syndrome and Middle-East Respiratory Syndrome, respectively [1,2,3,4]. Genomes of"/>
  <result pre="pathogenic coronaviruses responsible for previous epidemics of Severe Acute Respiratory" exact="Syndrome" post="and Middle-East Respiratory Syndrome, respectively [1,2,3,4]. Genomes of coronaviruses"/>
  <result pre="for previous epidemics of Severe Acute Respiratory Syndrome and Middle-East" exact="Respiratory" post="Syndrome, respectively [1,2,3,4]. Genomes of coronaviruses are typically organized"/>
  <result pre="HKU1, which are usually responsible for common colds and/or other" exact="respiratory" post="infections in children and older or immunocompromised individuals [5,6]."/>
  <result pre="which are usually responsible for common colds and/or other respiratory" exact="infections" post="in children and older or immunocompromised individuals [5,6]. On"/>
  <result pre="the WHO named the new coronavirus disease: COVID-19, alias COrona-VIrus" exact="Disease" post="2019. Two months later, following a large spread outside"/>
  <result pre="those of mild seasonal influenza. The remaining 20%, however, develop" exact="viral" post="interstitial pneumonia, requiring hospitalization. In approximately 5% of these"/>
  <result pre="pneumonia, requiring hospitalization. In approximately 5% of these patients, the" exact="pneumonia" post="is critical and requires intensive care. Overall mortality ranges"/>
  <result pre="no consensus on how to treat severe cases of COVID-19" exact="viral pneumonia." post="Thus far, all evidence of treatment options are derived"/>
  <result pre="response [14,15]. Each Coronaviridae family member codes for DUBs, named" exact="viral" post="papain-like proteases (PLPs), which remove ubiquitin from target proteins"/>
  <result pre="PLP, MERS-CoV PLP and SARS-CoV2 PLP respectively. For many coronaviruses," exact="viral" post="PLPs have been studied extensively and shown to play"/>
  <result pre="studied extensively and shown to play a crucial role during" exact="viral infection" post="of the host cell. These enzymes are multifunctional and"/>
  <result pre="extensively and shown to play a crucial role during viral" exact="infection" post="of the host cell. These enzymes are multifunctional and"/>
  <result pre="intrinsic cysteine protease and deISGylating activity that are required for" exact="viral" post="replication and the evasion of host responses [5,6]. The"/>
  <result pre="a regulator of the host cells innate immune response during" exact="viral" post="infections [16,17]. Since viral PLPs are used by coronaviruses"/>
  <result pre="regulator of the host cells innate immune response during viral" exact="infections" post="[16,17]. Since viral PLPs are used by coronaviruses to"/>
  <result pre="host cells innate immune response during viral infections [16,17]. Since" exact="viral" post="PLPs are used by coronaviruses to both replicate and"/>
  <result pre="immune response, they are considered important therapeutic targets for coronavirus" exact="infections" post="and thus may be of interest for future COVID-19"/>
  <result pre="3. Results 3.1. Role of PLPs in Coronaviruses Replication and" exact="Infection" post="Viral PLPs are highly conserved among the Nidovirales order"/>
  <result pre="Results 3.1. Role of PLPs in Coronaviruses Replication and Infection" exact="Viral" post="PLPs are highly conserved among the Nidovirales order members"/>
  <result pre="complex (RTC) is required to orchestrate the replication of the" exact="viral" post="units in the cytoplasm. Here, the PLPsâ€™ cysteine protease"/>
  <result pre="CoVs are known to adhere to this model and a" exact="visual" post="description of the SARS-CoV PLP role as a cysteine"/>
  <result pre="host cell innate immune response to viruses begins once the" exact="viral" post="nucleic acids are sensed by pattern recognition receptors such"/>
  <result pre="target genes, leading to the expression of several cytokines, including" exact="type I" post="IFNs (as Î± and Î² IFNs), which in turn"/>
  <result pre="dysregulation of the immune system in their pathogenic features at" exact="systemic" post="level [28,29]. Indeed, early research has shown that active"/>
  <result pre="their regulatory mechanisms [14,15], PLPs are believed to contribute to" exact="infection" post="pathogenesis by using their intrinsic DUB and deISGylating activities"/>
  <result pre="the proteins that mediate the intracellular sensing and signaling of" exact="viral infection," post="therefore leading to a dysregulation of the immune pathways,"/>
  <result pre="elucidate the exact interactions through which each coronaviral PLP promotes" exact="viral" post="infections, there are supporting evidences that the DUB activity"/>
  <result pre="or CXCL10 [39]. 3.1.3. PLPs as deISGylating Enzymes Once translated," exact="type I" post="IFNs activate the JAK-STAT pathway through the IFNs receptors"/>
  <result pre="by a three enzymes process, similar to Ub conjugation. During" exact="viral" post="infections, ISGylation seems to target a high number of"/>
  <result pre="the antiviral response [17]. ISGylation can antagonize the formation of" exact="viral" post="molecular complexes required for replication, activate molecules involved in"/>
  <result pre="act as a negative feedback for upstream factors. Interestingly, ISG15" exact="deficiency" post="in mice leads to increased and often deadly viral"/>
  <result pre="ISG15 deficiency in mice leads to increased and often deadly" exact="viral" post="infections, but in humans seems to involve increased susceptibility"/>
  <result pre="deadly viral infections, but in humans seems to involve increased" exact="susceptibility to" post="mycobacteria and dysregulated immune responses rather than viral infections"/>
  <result pre="increased susceptibility to mycobacteria and dysregulated immune responses rather than" exact="viral" post="infections [16]. There are well established evidence that coronaviral"/>
  <result pre="susceptibility to mycobacteria and dysregulated immune responses rather than viral" exact="infections" post="[16]. There are well established evidence that coronaviral PLPs"/>
  <result pre="elucidated, the exact consequences of PLPs deISGylating activity in coronavirus" exact="infections" post="are still poorly understood. However, two mouse models demonstrate"/>
  <result pre="in vivo that ISG15 has antiviral properties against a murine" exact="hepatitis" post="coronavirus [47] and that PLPs may disrupt them [48]."/>
  <result pre="enzymatic activities, other authors have demonstrated further effects on the" exact="infection" post="pathogenesis. The SARS-CoV PLP has been shown to complex"/>
  <result pre="of TGF-Î²1 activated genes, with an 8.4-fold reduction observed for" exact="type I" post="collagen [53]. Moreover, two recent papers have further investigated"/>
  <result pre="signaling and a pathogenic role of SARS-CoV PLP in inducing" exact="lung fibrosis" post="[54,55]. Furthermore, in a previous study, MG132 was also"/>
  <result pre="and removing the DUB activity of PLP2 in a murine" exact="hepatitis" post="virus also resulted in a better liver histology if"/>
  <result pre="coronavirus proteins may contribute to suppress the cellular responses to" exact="viral" post="infections [58,59,60], the role of PLPs in the production"/>
  <result pre="proteins may contribute to suppress the cellular responses to viral" exact="infections" post="[58,59,60], the role of PLPs in the production of"/>
  <result pre="anti-viral strategy. Collaterally, considering these effects of PLPs and other" exact="viral" post="proteins on dysregulating the innate immune response, one may"/>
  <result pre="replicated 10.3-fold less than the wild type in human airway" exact="epithelial" post="cells, but showed no differences in non IFN competent"/>
  <result pre="activity), leading to a four orders of magnitude decrease in" exact="viral" post="titer [67]. As the authors themselves recognize, the only"/>
  <result pre="survival, attributable to ISG15 restoration, while the wild type PLP" exact="virus infection" post="resulted in more than 80% mortality [48]. The treatment,"/>
  <result pre="attributable to ISG15 restoration, while the wild type PLP virus" exact="infection" post="resulted in more than 80% mortality [48]. The treatment,"/>
  <result pre="displaying increased level of ISGylation, was infected with a murine" exact="hepatitis" post="coronavirus. Higher ISGylation levels were positively correlated with a"/>
  <result pre="levels in vivo. Although, PLP2 inhibition was tested in vitro," exact="lower" post="viral titers were observed [47]. The latest, and second"/>
  <result pre="in vivo. Although, PLP2 inhibition was tested in vitro, lower" exact="viral" post="titers were observed [47]. The latest, and second main,"/>
  <result pre="main, PLP inhibition model in vivo is an engineered murine" exact="hepatitis" post="coronavirus. The DUB, and not the protease activity, of"/>
  <result pre="The DUB, and not the protease activity, of a murine" exact="hepatitis" post="coronavirus PLP2 was disrupted through structure guided mutagenesis. The"/>
  <result pre="technical issue, and suggests that PLPs may be essential for" exact="viral" post="replication. In summary, these three mouse models may confirm"/>
  <result pre="roles of PLPs enzymatic activities in the pathogenesis of coronaviruses" exact="infections" post="and give some promising insights on targeting PLPs as"/>
  <result pre="of a number of PLP inhibitors, that showed activity against" exact="viral" post="replication in cells [63,64,65,66]. Many active compounds against SARS-CoV"/>
  <result pre="compounds were isolated from Tribulus terrestris fruits and acted as" exact="mixed type" post="inhibitors with IC50 values of 15.6â€&quot;70.1 ÂµM against the"/>
  <result pre="a recent meta-analysis demonstrates a protective effect of flavonoids against" exact="upper" post="respiratory tract infections [80] and resveratrol has been found"/>
  <result pre="recent meta-analysis demonstrates a protective effect of flavonoids against upper" exact="respiratory" post="tract infections [80] and resveratrol has been found effective"/>
  <result pre="demonstrates a protective effect of flavonoids against upper respiratory tract" exact="infections" post="[80] and resveratrol has been found effective against MERS-CoV"/>
  <result pre="infections [80] and resveratrol has been found effective against MERS-CoV" exact="infection" post="in Vero E6 cells [81]. This could indicate that"/>
  <result pre="and is used as a biomarker of kidney [84] or" exact="brain" post="[85] injury, has antiviral properties [86,87,88] and was found"/>
  <result pre="reduced in Vero E6 cells infected with a porcine epidemic" exact="diarrhea" post="coronavirus [89]. Furthermore, it has been used at slightly"/>
  <result pre="at slightly supraphysiological levels in a previous study to reduce" exact="viral" post="titers of two human coronaviruses in cell cultures, where"/>
  <result pre="available drugs, thiopurine analogs, used to treat diseases such as" exact="cancer" post="or autoimmune diseases, may have been overlooked. They have"/>
  <result pre="thiopurine analogs, used to treat diseases such as cancer or" exact="autoimmune diseases," post="may have been overlooked. They have previously been shown"/>
  <result pre="would suggest a degree of caution in their use in" exact="infectious diseases." post="However, no evidence indicating a higher risk of COVID-19"/>
  <result pre="evidence indicating a higher risk of COVID-19 in patients under" exact="chronic" post="treatment with immunosuppressive drugs has been reported, although several"/>
  <result pre="have been proposed in vitro, i.e., alpha-interferon and cyclosporin [94]." exact="Severe" post="and advanced cases of COVID-19 pneumonias often involve immune"/>
  <result pre="in an antiviral and a double immunomodulatory efficacy: inhibiting the" exact="viral" post="replication, suppressing hyperinflammation damage and enhancing the endocellular innate"/>
  <result pre="that a recent report demonstrated that disulfiram (a clinically approved" exact="alcohol abuse" post="antagonist, now repurposed as an anticancer drug) can competitively"/>
  <result pre="results in the recentmurine model of DUB-mutated PLP2 in murine" exact="hepatitis" post="[57], suggests an involvement of PLP. However, a mechanism"/>
  <result pre="antiviral activity to m-calpain (a cysteine protease) inhibition, suggesting that" exact="viral" post="cysteine proteases, such as PLP, are possible targets of"/>
  <result pre="cysteine protease, DUB and deISGylating activities that contribute significantly to" exact="infection" post="pathogenesis. The efficacy of targeting PLPs as an antiviral"/>
  <result pre="This work was supported by the Department of Defense Ovarian" exact="Cancer" post="Research Program Grant OC160377, the Minnesota Ovarian Cancer Alliance,"/>
  <result pre="Defense Ovarian Cancer Research Program Grant OC160377, the Minnesota Ovarian" exact="Cancer" post="Alliance, the Randy Shaver Cancer Research Funds and the"/>
  <result pre="Grant OC160377, the Minnesota Ovarian Cancer Alliance, the Randy Shaver" exact="Cancer" post="Research Funds and the NIH grant 1R01GM130800-01A1 to Martina"/>
  <result pre="1R01GM130800-01A1 to Martina Bazzaro. This work was supported by the" exact="Swedish" post="Research Council to Padraig Dâ€™Arcy. This work was supported"/>
  <result pre="no conflict of interest. References References 1.GorbalenyaA.E.BakerS.C.BaricR.S.de GrootR.J.DrostenC.GulyaevaA.A.HaagmansB.L.LauberC.LeontovichA.M.NeumanB.W.et al.The species" exact="Severe" post="acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it"/>
  <result pre="conflict of interest. References References 1.GorbalenyaA.E.BakerS.C.BaricR.S.de GrootR.J.DrostenC.GulyaevaA.A.HaagmansB.L.LauberC.LeontovichA.M.NeumanB.W.et al.The species Severe" exact="acute" post="respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2Nat."/>
  <result pre="of interest. References References 1.GorbalenyaA.E.BakerS.C.BaricR.S.de GrootR.J.DrostenC.GulyaevaA.A.HaagmansB.L.LauberC.LeontovichA.M.NeumanB.W.et al.The species Severe acute" exact="respiratory" post="syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2Nat. Microbiol.2020553654410.1038/s41564-020-0695-z32123347"/>
  <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version)Mil. Med. Res.20207410.1186/s40779-020-0233-632029004 5.MielechA.M.ChenY.MesecarA.D.BakerS.C.Nidovirus papain-like proteases: Multifunctional enzymes"/>
  <result pre="Declares COVID-19 a PandemicActa Bio-Med. Atenei Parm.20209115716010.23750/abm.v91i1.9397 8.collab: Novel Coronavirus" exact="Pneumonia" post="Emergency Response Epidemiology Team[The epidemiological characteristics of an outbreak"/>
  <result pre="in the research of cytokine storm mechanism induced by Corona" exact="Virus Disease" post="2019 and the corresponding immunotherapies]Zhonghua Shao Shang Za Zhi"/>
  <result pre="the research of cytokine storm mechanism induced by Corona Virus" exact="Disease" post="2019 and the corresponding immunotherapies]Zhonghua Shao Shang Za Zhi"/>
  <result pre="Biochim. Biophys. Sin.20154714915510.1093/abbs/gmu13325651846 15.TangQ.WuP.ChenH.LiG.Pleiotropic roles of the ubiquitin-proteasome system during" exact="viral" post="propagationLife Sci.201820735035410.1016/j.lfs.2018.06.01429913185 16.DzimianskiJ.V.ScholteF.E.M.BergeronÃ‰.PeganS.D.ISG15: Itâ€™s ComplicatedJ. Mol. Biol.20194314203421610.1016/j.jmb.2019.03.01330890331 17.MoralesD.J.LenschowD.J.The Antiviral"/>
  <result pre="papain-like proteaseAntivir. Res.202017410466110.1016/j.antiviral.2019.10466131765674 20.Bailey-ElkinB.A.KnaapR.C.M.JohnsonG.G.DaleboutT.J.NinaberD.K.van KasterenP.B.BredenbeekP.J.SnijderE.J.KikkertM.MarkB.L.Crystal Structure of the Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates"/>
  <result pre="proteaseAntivir. Res.202017410466110.1016/j.antiviral.2019.10466131765674 20.Bailey-ElkinB.A.KnaapR.C.M.JohnsonG.G.DaleboutT.J.NinaberD.K.van KasterenP.B.BredenbeekP.J.SnijderE.J.KikkertM.MarkB.L.Crystal Structure of the Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted"/>
  <result pre="22.ChouC.-Y.LaiH.-Y.ChenH.-Y.ChengS.-C.ChengK.-W.ChouY.-W.Structural basis for catalysis and ubiquitin recognition by the severe" exact="acute" post="respiratory syndrome coronavirus papain-like proteaseActa Crystallogr. D Biol. Crystallogr.20147057258110.1107/S139900471303104024531491"/>
  <result pre="basis for catalysis and ubiquitin recognition by the severe acute" exact="respiratory" post="syndrome coronavirus papain-like proteaseActa Crystallogr. D Biol. Crystallogr.20147057258110.1107/S139900471303104024531491 23.ClasmanJ.R.BÃ¡ez-SantosY.M.MettelmanR.C.Oâ€™BrienA.BakerS.C.MesecarA.D.X-ray"/>
  <result pre="for catalysis and ubiquitin recognition by the severe acute respiratory" exact="syndrome" post="coronavirus papain-like proteaseActa Crystallogr. D Biol. Crystallogr.20147057258110.1107/S139900471303104024531491 23.ClasmanJ.R.BÃ¡ez-SantosY.M.MettelmanR.C.Oâ€™BrienA.BakerS.C.MesecarA.D.X-ray Structure"/>
  <result pre="DeISGylase Biochemical Activity from Papain-Like Protease Originating from Middle East" exact="Respiratory" post="Syndrome CoronavirusJ. Virol.201791e1067-1710.1128/JVI.01067-17 26.HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of Severe Acute Respiratory Syndrome"/>
  <result pre="Biochemical Activity from Papain-Like Protease Originating from Middle East Respiratory" exact="Syndrome" post="CoronavirusJ. Virol.201791e1067-1710.1128/JVI.01067-17 26.HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of Severe Acute Respiratory Syndrome Coronavirus"/>
  <result pre="Originating from Middle East Respiratory Syndrome CoronavirusJ. Virol.201791e1067-1710.1128/JVI.01067-17 26.HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of" exact="Severe" post="Acute Respiratory Syndrome Coronavirus Replicase Products and Characterization of"/>
  <result pre="from Middle East Respiratory Syndrome CoronavirusJ. Virol.201791e1067-1710.1128/JVI.01067-17 26.HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of Severe" exact="Acute" post="Respiratory Syndrome Coronavirus Replicase Products and Characterization of Papain-Like"/>
  <result pre="Middle East Respiratory Syndrome CoronavirusJ. Virol.201791e1067-1710.1128/JVI.01067-17 26.HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of Severe Acute" exact="Respiratory" post="Syndrome Coronavirus Replicase Products and Characterization of Papain-Like Protease"/>
  <result pre="East Respiratory Syndrome CoronavirusJ. Virol.201791e1067-1710.1128/JVI.01067-17 26.HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of Severe Acute Respiratory" exact="Syndrome" post="Coronavirus Replicase Products and Characterization of Papain-Like Protease ActivityJ."/>
  <result pre="Causes and consequences of cytokine storm and immunopathologySemin. Immunopathol.20173952953910.1007/s00281-017-0629-x28466096 29.ChannappanavarR.FehrA.R.VijayR.MackM.ZhaoJ.MeyerholzD.K.PerlmanS.Dysregulated" exact="Type I" post="Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in"/>
  <result pre="cytokine storm and immunopathologySemin. Immunopathol.20173952953910.1007/s00281-017-0629-x28466096 29.ChannappanavarR.FehrA.R.VijayR.MackM.ZhaoJ.MeyerholzD.K.PerlmanS.Dysregulated Type I Interferon and" exact="Inflammatory" post="Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected MiceCell Host"/>
  <result pre="Immunopathol.20173952953910.1007/s00281-017-0629-x28466096 29.ChannappanavarR.FehrA.R.VijayR.MackM.ZhaoJ.MeyerholzD.K.PerlmanS.Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause" exact="Lethal" post="Pneumonia in SARS-CoV-Infected MiceCell Host Microbe20161918119310.1016/j.chom.2016.01.00726867177 30.SpiegelM.PichlmairA.MartÃ­nez-SobridoL.CrosJ.GarcÃ­a-SastreA.HallerO.WeberF.Inhibition of Beta"/>
  <result pre="29.ChannappanavarR.FehrA.R.VijayR.MackM.ZhaoJ.MeyerholzD.K.PerlmanS.Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal" exact="Pneumonia" post="in SARS-CoV-Infected MiceCell Host Microbe20161918119310.1016/j.chom.2016.01.00726867177 30.SpiegelM.PichlmairA.MartÃ­nez-SobridoL.CrosJ.GarcÃ­a-SastreA.HallerO.WeberF.Inhibition of Beta Interferon"/>
  <result pre="SARS-CoV-Infected MiceCell Host Microbe20161918119310.1016/j.chom.2016.01.00726867177 30.SpiegelM.PichlmairA.MartÃ­nez-SobridoL.CrosJ.GarcÃ­a-SastreA.HallerO.WeberF.Inhibition of Beta Interferon Induction by" exact="Severe" post="Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for"/>
  <result pre="MiceCell Host Microbe20161918119310.1016/j.chom.2016.01.00726867177 30.SpiegelM.PichlmairA.MartÃ­nez-SobridoL.CrosJ.GarcÃ­a-SastreA.HallerO.WeberF.Inhibition of Beta Interferon Induction by Severe" exact="Acute" post="Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation"/>
  <result pre="Host Microbe20161918119310.1016/j.chom.2016.01.00726867177 30.SpiegelM.PichlmairA.MartÃ­nez-SobridoL.CrosJ.GarcÃ­a-SastreA.HallerO.WeberF.Inhibition of Beta Interferon Induction by Severe Acute" exact="Respiratory" post="Syndrome Coronavirus Suggests a Two-Step Model for Activation of"/>
  <result pre="Microbe20161918119310.1016/j.chom.2016.01.00726867177 30.SpiegelM.PichlmairA.MartÃ­nez-SobridoL.CrosJ.GarcÃ­a-SastreA.HallerO.WeberF.Inhibition of Beta Interferon Induction by Severe Acute Respiratory" exact="Syndrome" post="Coronavirus Suggests a Two-Step Model for Activation of Interferon"/>
  <result pre="31.YangX.ChenX.BianG.TuJ.XingY.WangY.ChenZ.Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East" exact="respiratory" post="syndrome coronavirus papain-like proteaseJ. Gen. Virol.20149561462610.1099/vir.0.059014-024362959 32.ClementzM.A.ChenZ.BanachB.S.WangY.SunL.RatiaK.Baez-SantosY.M.WangJ.TakayamaJ.GhoshA.K.et al.Deubiquitinating and"/>
  <result pre="processing, deubiquitinase and interferon antagonist activities of Middle East respiratory" exact="syndrome" post="coronavirus papain-like proteaseJ. Gen. Virol.20149561462610.1099/vir.0.059014-024362959 32.ClementzM.A.ChenZ.BanachB.S.WangY.SunL.RatiaK.Baez-SantosY.M.WangJ.TakayamaJ.GhoshA.K.et al.Deubiquitinating and Interferon"/>
  <result pre="of Coronavirus Papain-Like ProteasesJ. Virol.2010844619462910.1128/JVI.02406-0920181693 33.YuL.ZhangX.WuT.WangY.MengJ.LiuQ.NiuX.WuY.The papain-like protease of avian" exact="infectious" post="bronchitis virus has deubiquitinating activityArch. Virol.20171621943195010.1007/s00705-017-3328-y28316013 34.SuleaT.LindnerH.A.PurisimaE.O.MÃ©nardR.Deubiquitination, a New"/>
  <result pre="Coronavirus Papain-Like ProteasesJ. Virol.2010844619462910.1128/JVI.02406-0920181693 33.YuL.ZhangX.WuT.WangY.MengJ.LiuQ.NiuX.WuY.The papain-like protease of avian infectious" exact="bronchitis" post="virus has deubiquitinating activityArch. Virol.20171621943195010.1007/s00705-017-3328-y28316013 34.SuleaT.LindnerH.A.PurisimaE.O.MÃ©nardR.Deubiquitination, a New Function"/>
  <result pre="has deubiquitinating activityArch. Virol.20171621943195010.1007/s00705-017-3328-y28316013 34.SuleaT.LindnerH.A.PurisimaE.O.MÃ©nardR.Deubiquitination, a New Function of the" exact="Severe" post="Acute Respiratory Syndrome Coronavirus Papain-Like Protease?J. Virol.2005794550455110.1128/JVI.79.7.4550-4551.200515767458 35.HuX.TianJ.KangH.GuoD.LiuJ.LiuD.JiangQ.LiZ.QuJ.QuL.Transmissible Gastroenteritis"/>
  <result pre="deubiquitinating activityArch. Virol.20171621943195010.1007/s00705-017-3328-y28316013 34.SuleaT.LindnerH.A.PurisimaE.O.MÃ©nardR.Deubiquitination, a New Function of the Severe" exact="Acute" post="Respiratory Syndrome Coronavirus Papain-Like Protease?J. Virol.2005794550455110.1128/JVI.79.7.4550-4551.200515767458 35.HuX.TianJ.KangH.GuoD.LiuJ.LiuD.JiangQ.LiZ.QuJ.QuL.Transmissible Gastroenteritis Virus"/>
  <result pre="activityArch. Virol.20171621943195010.1007/s00705-017-3328-y28316013 34.SuleaT.LindnerH.A.PurisimaE.O.MÃ©nardR.Deubiquitination, a New Function of the Severe Acute" exact="Respiratory" post="Syndrome Coronavirus Papain-Like Protease?J. Virol.2005794550455110.1128/JVI.79.7.4550-4551.200515767458 35.HuX.TianJ.KangH.GuoD.LiuJ.LiuD.JiangQ.LiZ.QuJ.QuL.Transmissible Gastroenteritis Virus Papain-Like"/>
  <result pre="Virol.20171621943195010.1007/s00705-017-3328-y28316013 34.SuleaT.LindnerH.A.PurisimaE.O.MÃ©nardR.Deubiquitination, a New Function of the Severe Acute Respiratory" exact="Syndrome" post="Coronavirus Papain-Like Protease?J. Virol.2005794550455110.1128/JVI.79.7.4550-4551.200515767458 35.HuX.TianJ.KangH.GuoD.LiuJ.LiuD.JiangQ.LiZ.QuJ.QuL.Transmissible Gastroenteritis Virus Papain-Like Protease"/>
  <result pre="Deubiquitinase ActivityBioMed Res. Int.20172017708909110.1155/2017/708909129201911 36.XingY.ChenJ.TuJ.ZhangB.ChenX.ShiH.BakerS.C.FengL.ChenZ.The papain-like protease of porcine epidemic" exact="diarrhea" post="virus negatively regulates type I interferon pathway by acting"/>
  <result pre="36.XingY.ChenJ.TuJ.ZhangB.ChenX.ShiH.BakerS.C.FengL.ChenZ.The papain-like protease of porcine epidemic diarrhea virus negatively regulates" exact="type I" post="interferon pathway by acting as a viral deubiquitinaseJ. Gen."/>
  <result pre="negatively regulates type I interferon pathway by acting as a" exact="viral" post="deubiquitinaseJ. Gen. Virol.201394 Pt 71554156710.1099/vir.0.051169-023596270 37.ZhengD.ChenG.GuoB.ChengG.TangH.PLP2, a potent deubiquitinase"/>
  <result pre="Gen. Virol.201394 Pt 71554156710.1099/vir.0.051169-023596270 37.ZhengD.ChenG.GuoB.ChengG.TangH.PLP2, a potent deubiquitinase from murine" exact="hepatitis" post="virus, strongly inhibits cellular type I interferon productionCell Res.2008181105111310.1038/cr.2008.29418957937"/>
  <result pre="a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular" exact="type I" post="interferon productionCell Res.2008181105111310.1038/cr.2008.29418957937 38.WangG.ChenG.ZhengD.ChengG.TangH.PLP2 of Mouse Hepatitis Virus A59"/>
  <result pre="strongly inhibits cellular type I interferon productionCell Res.2008181105111310.1038/cr.2008.29418957937 38.WangG.ChenG.ZhengD.ChengG.TangH.PLP2 of" exact="Mouse" post="Hepatitis Virus A59 (MHV-A59) Targets TBK1 to Negatively Regulate"/>
  <result pre="inhibits cellular type I interferon productionCell Res.2008181105111310.1038/cr.2008.29418957937 38.WangG.ChenG.ZhengD.ChengG.TangH.PLP2 of Mouse" exact="Hepatitis" post="Virus A59 (MHV-A59) Targets TBK1 to Negatively Regulate Cellular"/>
  <result pre="Hepatitis Virus A59 (MHV-A59) Targets TBK1 to Negatively Regulate Cellular" exact="Type I" post="Interferon Signaling PathwayPLoS ONE20116e1719210.1371/journal.pone.001719221364999 39.MielechA.M.KilianskiA.Baez-SantosY.M.MesecarA.D.BakerS.C.MERS-CoV papain-like protease has deISGylating"/>
  <result pre="papain-like protease domain of the SARS coronavirusJ. Biol. Chem.2007282322083222110.1074/jbc.M70487020017761676 41.FriemanM.RatiaK.JohnstonR.E.MesecarA.D.BaricR.S.Severe" exact="Acute" post="Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic"/>
  <result pre="protease domain of the SARS coronavirusJ. Biol. Chem.2007282322083222110.1074/jbc.M70487020017761676 41.FriemanM.RatiaK.JohnstonR.E.MesecarA.D.BaricR.S.Severe Acute" exact="Respiratory" post="Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain"/>
  <result pre="domain of the SARS coronavirusJ. Biol. Chem.2007282322083222110.1074/jbc.M70487020017761676 41.FriemanM.RatiaK.JohnstonR.E.MesecarA.D.BaricR.S.Severe Acute Respiratory" exact="Syndrome" post="Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate"/>
  <result pre="of STING-Mediated SignalingPLoS ONE20127e3080210.1371/journal.pone.003080222312431 44.ChenX.YangX.ZhengY.YangY.XingY.ChenZ.SARS coronavirus papain-like protease inhibits the" exact="type I" post="interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complexProtein"/>
  <result pre="via E3 ubiquitin ligase RCHY1Proc. Natl. Acad. Sci. USA2016113E5192E520110.1073/pnas.160343511327519799 52.LiS.-W.LaiC.-C.PingJ.-F.TsaiF.-J.WanL.LinY.-J.KungS.-H.LinC.-W.Severe" exact="acute" post="respiratory syndrome coronavirus papain-like protease suppressed alpha interferon-induced responses"/>
  <result pre="E3 ubiquitin ligase RCHY1Proc. Natl. Acad. Sci. USA2016113E5192E520110.1073/pnas.160343511327519799 52.LiS.-W.LaiC.-C.PingJ.-F.TsaiF.-J.WanL.LinY.-J.KungS.-H.LinC.-W.Severe acute" exact="respiratory" post="syndrome coronavirus papain-like protease suppressed alpha interferon-induced responses through"/>
  <result pre="ubiquitin ligase RCHY1Proc. Natl. Acad. Sci. USA2016113E5192E520110.1073/pnas.160343511327519799 52.LiS.-W.LaiC.-C.PingJ.-F.TsaiF.-J.WanL.LinY.-J.KungS.-H.LinC.-W.Severe acute respiratory" exact="syndrome" post="coronavirus papain-like protease suppressed alpha interferon-induced responses through downregulation"/>
  <result pre="53.LiS.-W.YangT.-C.WanL.LinY.-J.TsaiF.-J.LaiC.-C.LinC.-W.Correlation between TGF-Î²1 expression and proteomic profiling induced by severe" exact="acute" post="respiratory syndrome coronavirus papain-like proteaseProteomics2012123193320510.1002/pmic.20120022522936401 54.LiS.-W.WangC.-Y.JouY.-J.YangT.-C.HuangS.-H.WanL.LinY.-J.LinC.-W.SARS coronavirus papain-like protease"/>
  <result pre="between TGF-Î²1 expression and proteomic profiling induced by severe acute" exact="respiratory" post="syndrome coronavirus papain-like proteaseProteomics2012123193320510.1002/pmic.20120022522936401 54.LiS.-W.WangC.-Y.JouY.-J.YangT.-C.HuangS.-H.WanL.LinY.-J.LinC.-W.SARS coronavirus papain-like protease induces"/>
  <result pre="TGF-Î²1 expression and proteomic profiling induced by severe acute respiratory" exact="syndrome" post="coronavirus papain-like proteaseProteomics2012123193320510.1002/pmic.20120022522936401 54.LiS.-W.WangC.-Y.JouY.-J.YangT.-C.HuangS.-H.WanL.LinY.-J.LinC.-W.SARS coronavirus papain-like protease induces Egr-1-dependent"/>
  <result pre="signalingVirus Res.2017235586610.1016/j.virusres.2017.04.00828414040 56.MaX.-Z.BartczakA.ZhangJ.KhattarR.ChenL.LiuM.F.EdwardsA.LevyG.McGilvrayI.D.Proteasome Inhibition In Vivo Promotes Survival in a" exact="Lethal" post="Murine Model of Severe Acute Respiratory SyndromeJ. Virol.201084124191242810.1128/JVI.01219-1020861244 57.DengX.ChenY.MielechA.M.HackbartM.KeselyK.R.MettelmanR.C.Oâ€™BrienA.ChapmanM.E.MesecarA.D.BakerS.C.Structure-Guided"/>
  <result pre="In Vivo Promotes Survival in a Lethal Murine Model of" exact="Severe" post="Acute Respiratory SyndromeJ. Virol.201084124191242810.1128/JVI.01219-1020861244 57.DengX.ChenY.MielechA.M.HackbartM.KeselyK.R.MettelmanR.C.Oâ€™BrienA.ChapmanM.E.MesecarA.D.BakerS.C.Structure-Guided Mutagenesis Alters Deubiquitinating Activity"/>
  <result pre="Vivo Promotes Survival in a Lethal Murine Model of Severe" exact="Acute" post="Respiratory SyndromeJ. Virol.201084124191242810.1128/JVI.01219-1020861244 57.DengX.ChenY.MielechA.M.HackbartM.KeselyK.R.MettelmanR.C.Oâ€™BrienA.ChapmanM.E.MesecarA.D.BakerS.C.Structure-Guided Mutagenesis Alters Deubiquitinating Activity and"/>
  <result pre="Promotes Survival in a Lethal Murine Model of Severe Acute" exact="Respiratory" post="SyndromeJ. Virol.201084124191242810.1128/JVI.01219-1020861244 57.DengX.ChenY.MielechA.M.HackbartM.KeselyK.R.MettelmanR.C.Oâ€™BrienA.ChapmanM.E.MesecarA.D.BakerS.C.Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates"/>
  <result pre="nucleocapsid protein: A protein with multifarious activitiesInfect. Genet. Evol.2008839740510.1016/j.meegid.2007.07.00417881296 60.Kopecky-BrombergS.A.MartÃ­nez-SobridoL.FriemanM.BaricR.A.PaleseP.Severe" exact="acute" post="respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF"/>
  <result pre="protein: A protein with multifarious activitiesInfect. Genet. Evol.2008839740510.1016/j.meegid.2007.07.00417881296 60.Kopecky-BrombergS.A.MartÃ­nez-SobridoL.FriemanM.BaricR.A.PaleseP.Severe acute" exact="respiratory" post="syndrome coronavirus open reading frame (ORF) 3b, ORF 6,"/>
  <result pre="A protein with multifarious activitiesInfect. Genet. Evol.2008839740510.1016/j.meegid.2007.07.00417881296 60.Kopecky-BrombergS.A.MartÃ­nez-SobridoL.FriemanM.BaricR.A.PaleseP.Severe acute respiratory" exact="syndrome" post="coronavirus open reading frame (ORF) 3b, ORF 6, and"/>
  <result pre="of a Series of Novel and Reversible Inhibitors for the" exact="Severe" post="Acute Respiratory Syndromeâˆ’Coronavirus Papain-Like ProteaseJ. Med. Chem.2009525228524010.1021/jm900611t19645480 65.GhoshA.K.TakayamaJ.RaoK.V.RatiaK.ChaudhuriR.MulhearnD.C.LeeH.NicholsD.B.BalijiS.BakerS.C.et al.Severe"/>
  <result pre="a Series of Novel and Reversible Inhibitors for the Severe" exact="Acute" post="Respiratory Syndromeâˆ’Coronavirus Papain-Like ProteaseJ. Med. Chem.2009525228524010.1021/jm900611t19645480 65.GhoshA.K.TakayamaJ.RaoK.V.RatiaK.ChaudhuriR.MulhearnD.C.LeeH.NicholsD.B.BalijiS.BakerS.C.et al.Severe Acute"/>
  <result pre="Series of Novel and Reversible Inhibitors for the Severe Acute" exact="Respiratory" post="Syndromeâˆ’Coronavirus Papain-Like ProteaseJ. Med. Chem.2009525228524010.1021/jm900611t19645480 65.GhoshA.K.TakayamaJ.RaoK.V.RatiaK.ChaudhuriR.MulhearnD.C.LeeH.NicholsD.B.BalijiS.BakerS.C.et al.Severe Acute Respiratory"/>
  <result pre="Severe Acute Respiratory Syndromeâˆ’Coronavirus Papain-Like ProteaseJ. Med. Chem.2009525228524010.1021/jm900611t19645480 65.GhoshA.K.TakayamaJ.RaoK.V.RatiaK.ChaudhuriR.MulhearnD.C.LeeH.NicholsD.B.BalijiS.BakerS.C.et al.Severe" exact="Acute" post="Respiratory Syndrome-Coronavirus Papain-Like Novel Protease Inhibitors: Design, Synthesis, Protein-Ligand"/>
  <result pre="Acute Respiratory Syndromeâˆ’Coronavirus Papain-Like ProteaseJ. Med. Chem.2009525228524010.1021/jm900611t19645480 65.GhoshA.K.TakayamaJ.RaoK.V.RatiaK.ChaudhuriR.MulhearnD.C.LeeH.NicholsD.B.BalijiS.BakerS.C.et al.Severe Acute" exact="Respiratory" post="Syndrome-Coronavirus Papain-Like Novel Protease Inhibitors: Design, Synthesis, Protein-Ligand X-ray"/>
  <result pre="Synthesis, Protein-Ligand X-ray Structure and Biological EvaluationJ. Med. Chem.2010534968497910.1021/jm100448920527968 66.BÃ¡ez-SantosY.M.BarrazaS.J.WilsonM.W.AgiusM.P.MielechA.M.DavisN.M.BakerS.C.LarsenS.D.MesecarA.D.X-ray" exact="Structural" post="and Biological Evaluation of a Series of Potent and"/>
  <result pre="and Biological Evaluation of a Series of Potent and Highly" exact="Selective" post="Inhibitors of Human Coronavirus Papain-like ProteasesJ. Med. Chem.2014572393241210.1021/jm401712t24568342 67.ZhangW.Bailey-ElkinB.A.KnaapR.C.M.KhareB.DaleboutT.J.JohnsonG.G.van"/>
  <result pre="Psoralea corylifoliaJ. Enzyme Inhib. Med. Chem.201429596310.3109/14756366.2012.75359123323951 75.TsaiY.-C.LeeC.-L.YenH.-R.ChangY.-S.LinY.-P.HuangS.-H.LinC.-W.Antiviral Action of Tryptanthrin" exact="Isolated" post="from Strobilanthes cusia Leaf against Human Coronavirus NL63Biomolecules20201036610.3390/biom1003036632120929 76.ChouC.-Y.ChienC.-H.HanY.-S.PrebandaM.T.HsiehH.-P.TurkB.ChangG.-G.ChenX.Thiopurine"/>
  <result pre="Human Coronavirus NL63Biomolecules20201036610.3390/biom1003036632120929 76.ChouC.-Y.ChienC.-H.HanY.-S.PrebandaM.T.HsiehH.-P.TurkB.ChangG.-G.ChenX.Thiopurine analogues inhibit papain-like protease of severe" exact="acute" post="respiratory syndrome coronavirusBiochem. Pharmacol.2008751601160910.1016/j.bcp.2008.01.00518313035 77.ChengK.-W.ChengS.-C.ChenW.-Y.LinM.-H.ChuangS.-J.ChengI.-H.SunC.-Y.ChouC.-Y.Thiopurine analogs and mycophenolic acid"/>
  <result pre="Coronavirus NL63Biomolecules20201036610.3390/biom1003036632120929 76.ChouC.-Y.ChienC.-H.HanY.-S.PrebandaM.T.HsiehH.-P.TurkB.ChangG.-G.ChenX.Thiopurine analogues inhibit papain-like protease of severe acute" exact="respiratory" post="syndrome coronavirusBiochem. Pharmacol.2008751601160910.1016/j.bcp.2008.01.00518313035 77.ChengK.-W.ChengS.-C.ChenW.-Y.LinM.-H.ChuangS.-J.ChengI.-H.SunC.-Y.ChouC.-Y.Thiopurine analogs and mycophenolic acid synergistically"/>
  <result pre="NL63Biomolecules20201036610.3390/biom1003036632120929 76.ChouC.-Y.ChienC.-H.HanY.-S.PrebandaM.T.HsiehH.-P.TurkB.ChangG.-G.ChenX.Thiopurine analogues inhibit papain-like protease of severe acute respiratory" exact="syndrome" post="coronavirusBiochem. Pharmacol.2008751601160910.1016/j.bcp.2008.01.00518313035 77.ChengK.-W.ChengS.-C.ChenW.-Y.LinM.-H.ChuangS.-J.ChengI.-H.SunC.-Y.ChouC.-Y.Thiopurine analogs and mycophenolic acid synergistically inhibit"/>
  <result pre="mycophenolic acid synergistically inhibit the papain-like protease of Middle East" exact="respiratory" post="syndrome coronavirusAntivir. Res.201511591610.1016/j.antiviral.2014.12.01125542975 78.LinM.-H.MosesD.C.HsiehC.-H.ChengS.-C.ChenY.-H.SunC.-Y.ChouC.-Y.Disulfiram can inhibit MERS and SARS"/>
  <result pre="acid synergistically inhibit the papain-like protease of Middle East respiratory" exact="syndrome" post="coronavirusAntivir. Res.201511591610.1016/j.antiviral.2014.12.01125542975 78.LinM.-H.MosesD.C.HsiehC.-H.ChengS.-C.ChenY.-H.SunC.-Y.ChouC.-Y.Disulfiram can inhibit MERS and SARS coronavirus"/>
  <result pre="on human coronavirusesAntimicrob. Agents Chemother.1991352444244610.1128/AAC.35.11.24441804023 80.SomervilleV.S.BraakhuisA.J.HopkinsW.G.Effect of Flavonoids on Upper" exact="Respiratory" post="Tract Infections and Immune Function: A Systematic Review and"/>
  <result pre="human coronavirusesAntimicrob. Agents Chemother.1991352444244610.1128/AAC.35.11.24441804023 80.SomervilleV.S.BraakhuisA.J.HopkinsW.G.Effect of Flavonoids on Upper Respiratory" exact="Tract" post="Infections and Immune Function: A Systematic Review and Meta-AnalysisAdv."/>
  <result pre="coronavirusesAntimicrob. Agents Chemother.1991352444244610.1128/AAC.35.11.24441804023 80.SomervilleV.S.BraakhuisA.J.HopkinsW.G.Effect of Flavonoids on Upper Respiratory Tract" exact="Infections" post="and Immune Function: A Systematic Review and Meta-AnalysisAdv. Nutr.2016748849710.3945/an.115.01053827184276"/>
  <result pre="A Systematic Review and Meta-AnalysisAdv. Nutr.2016748849710.3945/an.115.01053827184276 81.LinS.-C.HoC.-T.ChuoW.-H.LiS.WangT.T.LinC.-C.Effective inhibition of MERS-CoV" exact="infection" post="by resveratrolBMC Infect. Dis.20171714410.1186/s12879-017-2253-828193191 82.KalusU.KiesewetterH.RadtkeH.Effect of CYSTUS052 and green"/>
  <result pre="CYSTUS052 and green tea on subjective symptoms in patients with" exact="infection" post="of the upper respiratory tractPhytother. Res. PTR2010249610010.1002/ptr.287619444821 83.KalusU.GrigorovA.KadeckiO.JansenJ.-P.KiesewetterH.RadtkeH.Cistus incanus"/>
  <result pre="tea on subjective symptoms in patients with infection of the" exact="upper" post="respiratory tractPhytother. Res. PTR2010249610010.1002/ptr.287619444821 83.KalusU.GrigorovA.KadeckiO.JansenJ.-P.KiesewetterH.RadtkeH.Cistus incanus (CYSTUS052) for treating"/>
  <result pre="on subjective symptoms in patients with infection of the upper" exact="respiratory" post="tractPhytother. Res. PTR2010249610010.1002/ptr.287619444821 83.KalusU.GrigorovA.KadeckiO.JansenJ.-P.KiesewetterH.RadtkeH.Cistus incanus (CYSTUS052) for treating patients"/>
  <result pre="tractPhytother. Res. PTR2010249610010.1002/ptr.287619444821 83.KalusU.GrigorovA.KadeckiO.JansenJ.-P.KiesewetterH.RadtkeH.Cistus incanus (CYSTUS052) for treating patients with" exact="infection" post="of the upper respiratory tract. A prospective, randomised, placebo-controlled"/>
  <result pre="83.KalusU.GrigorovA.KadeckiO.JansenJ.-P.KiesewetterH.RadtkeH.Cistus incanus (CYSTUS052) for treating patients with infection of the" exact="upper" post="respiratory tract. A prospective, randomised, placebo-controlled clinical studyAntivir. Res.20098426727110.1016/j.antiviral.2009.10.00119828122"/>
  <result pre="incanus (CYSTUS052) for treating patients with infection of the upper" exact="respiratory" post="tract. A prospective, randomised, placebo-controlled clinical studyAntivir. Res.20098426727110.1016/j.antiviral.2009.10.00119828122 84.CanneyM.SextonD.J.Oâ€™LearyN.HealyM.KennyR.A.LittleM.A.Oâ€™SeaghdhaC.M.Examining"/>
  <result pre="the utility of cystatin C as a confirmatory test of" exact="chronic" post="kidney disease across the age range in middle-aged and"/>
  <result pre="utility of cystatin C as a confirmatory test of chronic" exact="kidney disease" post="across the age range in middle-aged and older community-dwelling"/>
  <result pre="of cystatin C as a confirmatory test of chronic kidney" exact="disease" post="across the age range in middle-aged and older community-dwelling"/>
  <result pre="Behav.20199e0146210.1002/brb3.146231701661 86.BjÃ¶rckL.GrubbA.KjellÃ©nL.Cystatin C, a human proteinase inhibitor, blocks replication of" exact="herpes" post="simplex virusJ. Virol.19906494194310.1128/JVI.64.2.941-943.19902153254 87.VernekarV.VelhalS.BandivdekarA.Evaluation of cystatin C activities against"/>
  <result pre="C in human cell linesFEBS J.20082754571458210.1111/j.1742-4658.2008.06600.x18699780 91.ChenX.ChouC.-Y.ChangG.-G.Thiopurine Analogue Inhibitors of" exact="Severe" post="Acute Respiratory Syndrome-Coronavirus Papain-Like Protease, a Deubiquitinating and deISGylating"/>
  <result pre="in human cell linesFEBS J.20082754571458210.1111/j.1742-4658.2008.06600.x18699780 91.ChenX.ChouC.-Y.ChangG.-G.Thiopurine Analogue Inhibitors of Severe" exact="Acute" post="Respiratory Syndrome-Coronavirus Papain-Like Protease, a Deubiquitinating and deISGylating EnzymeAntivir."/>
  <result pre="human cell linesFEBS J.20082754571458210.1111/j.1742-4658.2008.06600.x18699780 91.ChenX.ChouC.-Y.ChangG.-G.Thiopurine Analogue Inhibitors of Severe Acute" exact="Respiratory" post="Syndrome-Coronavirus Papain-Like Protease, a Deubiquitinating and deISGylating EnzymeAntivir. Chem."/>
  <result pre="a Deubiquitinating and deISGylating EnzymeAntivir. Chem. Chemother.20091915115610.1177/09563202090190040219374142 92.MonteleoneG.ArdizzoneS.Are Patients with" exact="Inflammatory" post="Bowel Disease at Increased Risk for Covid-19 Infection?J. Crohns"/>
  <result pre="and deISGylating EnzymeAntivir. Chem. Chemother.20091915115610.1177/09563202090190040219374142 92.MonteleoneG.ArdizzoneS.Are Patients with Inflammatory Bowel" exact="Disease" post="at Increased Risk for Covid-19 Infection?J. Crohns Colitis202010.1093/ecco-jcc/jjaa06132215548 93.Dâ€™AntigaL.Coronaviruses"/>
  <result pre="EnzymeAntivir. Chem. Chemother.20091915115610.1177/09563202090190040219374142 92.MonteleoneG.ArdizzoneS.Are Patients with Inflammatory Bowel Disease at" exact="Increased" post="Risk for Covid-19 Infection?J. Crohns Colitis202010.1093/ecco-jcc/jjaa06132215548 93.Dâ€™AntigaL.Coronaviruses and immunosuppressed"/>
  <result pre="and cyclosporine treatment separately and in combination on Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and"/>
  <result pre="cyclosporine treatment separately and in combination on Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo"/>
  <result pre="and immunosuppressionLancet20203951033103410.1016/S0140-6736(20)30628-032192578 96.YannakiE.PapadopoulouA.AthanasiouE.KaloyannidisP.ParaskevaA.BougiouklisD.PalladasP.YiangouM.AnagnostopoulosA.The proteasome inhibitor bortezomib drastically affects inflammation and" exact="bone disease" post="in adjuvant-induced arthritis in ratsArthritis Rheum.2010623277328810.1002/art.2769020722034 97.YuG.-Y.LaiM.M.C.The ubiquitin-proteasome system"/>
  <result pre="immunosuppressionLancet20203951033103410.1016/S0140-6736(20)30628-032192578 96.YannakiE.PapadopoulouA.AthanasiouE.KaloyannidisP.ParaskevaA.BougiouklisD.PalladasP.YiangouM.AnagnostopoulosA.The proteasome inhibitor bortezomib drastically affects inflammation and bone" exact="disease" post="in adjuvant-induced arthritis in ratsArthritis Rheum.2010623277328810.1002/art.2769020722034 97.YuG.-Y.LaiM.M.C.The ubiquitin-proteasome system"/>
  <result pre="inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced" exact="arthritis" post="in ratsArthritis Rheum.2010623277328810.1002/art.2769020722034 97.YuG.-Y.LaiM.M.C.The ubiquitin-proteasome system facilitates the transfer"/>
  <result pre="coronavirus from endosome to cytoplasm during virus entryJ. Virol.20057964464810.1128/JVI.79.1.644-648.200515596861 98.SchneiderM.AckermannK.StuartM.WexC.ProtzerU.SchÃ¤tzlH.M.GilchS.Severe" exact="Acute" post="Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132"/>
  <result pre="from endosome to cytoplasm during virus entryJ. Virol.20057964464810.1128/JVI.79.1.644-648.200515596861 98.SchneiderM.AckermannK.StuartM.WexC.ProtzerU.SchÃ¤tzlH.M.GilchS.Severe Acute" exact="Respiratory" post="Syndrome Coronavirus Replication Is Severely Impaired by MG132 due"/>
  <result pre="endosome to cytoplasm during virus entryJ. Virol.20057964464810.1128/JVI.79.1.644-648.200515596861 98.SchneiderM.AckermannK.StuartM.WexC.ProtzerU.SchÃ¤tzlH.M.GilchS.Severe Acute Respiratory" exact="Syndrome" post="Coronavirus Replication Is Severely Impaired by MG132 due to"/>
  <result pre="MG132 due to Proteasome-Independent Inhibition of M-CalpainJ. Virol.201286101121012210.1128/JVI.01001-1222787216 99.BarnardD.L.HubbardV.D.BurtonJ.SmeeD.F.MorreyJ.D.OttoM.J.SidwellR.W.Inhibition of" exact="Severe" post="Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and"/>
  <result pre="due to Proteasome-Independent Inhibition of M-CalpainJ. Virol.201286101121012210.1128/JVI.01001-1222787216 99.BarnardD.L.HubbardV.D.BurtonJ.SmeeD.F.MorreyJ.D.OttoM.J.SidwellR.W.Inhibition of Severe" exact="Acute" post="Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and Î²-D-N4-HydroxycytidineAntivir."/>
  <result pre="to Proteasome-Independent Inhibition of M-CalpainJ. Virol.201286101121012210.1128/JVI.01001-1222787216 99.BarnardD.L.HubbardV.D.BurtonJ.SmeeD.F.MorreyJ.D.OttoM.J.SidwellR.W.Inhibition of Severe Acute" exact="Respiratory" post="Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and Î²-D-N4-HydroxycytidineAntivir. Chem."/>
  <result pre="Chemother.200415152210.1177/09563202040150010215074711 Figure 1 Schematic representation of the role of severe" exact="acute" post="respiratory syndrome (SARS)-coronavirus (CoV) papain-like protease (PLP) role during"/>
  <result pre="Figure 1 Schematic representation of the role of severe acute" exact="respiratory" post="syndrome (SARS)-coronavirus (CoV) papain-like protease (PLP) role during infection."/>
  <result pre="1 Schematic representation of the role of severe acute respiratory" exact="syndrome" post="(SARS)-coronavirus (CoV) papain-like protease (PLP) role during infection. The"/>
  <result pre="state. Finally, IRF3 and NF-kB promote the activation of the" exact="type I" post="INF antiviral response. The PLP DUB activity antagonizes these"/>
  <result pre="steps, resulting in a global antagonism of the signaling and" exact="lower" post="activation of INF-Î². For a detailed description of the"/>
 </snippets>
</snippetsTree>
